| Dr Yuanhong Wang, MD | |
|
1050 W Perimeter Rd, 79mdss/sgsc, Andrews Afb, MD 20762-6601 | |
| (240) 857-8202 | |
| (240) 857-3121 |
| Full Name | Dr Yuanhong Wang |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1050 W Perimeter Rd, Andrews Afb, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073601530 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 054360 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yuanhong Wang, MD 1050 West Perimeter Rd, 79mdss/sgsc, Andrews Afb, MD 20762 Ph: (240) 857-8202 | Dr Yuanhong Wang, MD 1050 W Perimeter Rd, 79mdss/sgsc, Andrews Afb, MD 20762-6601 Ph: (240) 857-8202 |
News Archive
Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced President and CEO Marvin R. Richardson and CFO Matthew Middendorf will attend the Barrington Research Healthcare Conference on Tuesday, August 25.
BD, a leading global medical technology company, and Rady Children's Hospital-San Diego today announced that they have implemented an innovative pilot program at the Hospital that is designed to safely divert a significant percentage of BD sharps waste from landfills and utilize the recycled materials.
At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery.
Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition, Weight loss products, and Contract Manufacturing services, and Innovative laboratories, one of the fastest-growing Weight Loss brands in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire Innovative's brand of Diet Aids.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced the availability of VALSTAR(TM) (valrubicin) for the treatment of a distinct form of bladder cancer. VALSTAR is the only FDA-approved intravesical therapy for patients with Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder for whom immediate removal of the bladder would be associated with unacceptable medical risks.
› Verified 9 days ago
Dr. James H Berro, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 79 Mdss/sgsc, 1050 W. Perimeter Rd, Suite G1-30, Andrews Afb, MD 20762 Phone: 240-857-8116 Fax: 240-857-3121 |